Finance

Beta
Lists
PLYX:NASDAQ
Polaryx Therapeutics, Inc
$2.33
-7.91%
(-0.20) 1D
$2.46
+5.79% (+0.13)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PLYX...
Open
$2.55
High
$2.57
Low
$2.28
Mkt. cap
116.14M
Avg. vol.
304.47K
Volume
220.36K
52-wk high
$48.91
52-wk low
$2.07
No. of employees
7
Open
$2.55
High
$2.57
Low
$2.28
Mkt. cap
116.14M
Avg. vol.
304.47K
Volume
220.36K
52-wk high
$48.91
52-wk low
$2.07
No. of employees
7
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to PLYX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for PLYX in the last 3 months.
Highest
Current $2.33
$10.00 (+329.18%)
Average
$10.00 (+329.18%)
Lowest
$10.00 (+329.18%)
News stories
From sources across the web
About Polaryx Therapeutics, Inc
CEO-
Employees7
Founded2014
HeadquartersParamus, New Jersey, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
476.00K
514.00K
560.00K
679.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
408.00K
460.00K
351.00K
1.28M
Operating expense
884.00K
974.00K
911.00K
1.96M
Total operating expenses
884.00K
974.00K
911.00K
1.96M
Operating income
-884.00K
-974.00K
-911.00K
-1.96M
Other non operating income
-124.00K
-456.00K
-584.00K
-586.00K
EBT including unusual items
-1.01M
-1.43M
-1.50M
-2.54M
EBT excluding unusual items
-1.01M
-1.43M
-1.50M
-2.54M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.01M
-1.43M
-1.50M
-2.54M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more